Stage IV Cutaneous Melanoma AJCC v6 and v7
Showing 1 - 25 of 29
Acral Lentiginous Melanoma, Cutaneous Nodular Melanoma, Lentigo Maligna Melanoma Trial in United States (Dinaciclib)
Active, not recruiting
- Acral Lentiginous Melanoma
- +6 more
-
Mobile, Alabama
- +190 more
Jan 28, 2023
Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma, Metastatic Non-Cutaneous Melanoma Trial in Canada, Ireland, United
Active, not recruiting
- Metastatic Cutaneous Melanoma
- +15 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +582 more
Jan 28, 2023
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,
Active, not recruiting
- Metastatic Melanoma
- +6 more
- Ibrutinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 13, 2023
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Active, not recruiting
- Stage III Cutaneous Melanoma AJCC v7
- +4 more
- Cryosurgery
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 3, 2023
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,
Active, not recruiting
- Metastatic Melanoma
- +3 more
- Imiquimod
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 3, 2023
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Completed
- Stage III Cutaneous Melanoma AJCC v7
- +5 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2022
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Completed
- Metastatic Melanoma
- +3 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Advanced Melanoma, Melanoma of Unknown Primary, Mucosal Melanoma Trial in United States (Ipilimumab, Nivolumab)
Active, not recruiting
- Advanced Melanoma
- +10 more
- Ipilimumab
- Nivolumab
-
Anchorage, Alaska
- +638 more
Aug 30, 2022
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston
Active, not recruiting
- Metastatic Melanoma
- +2 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States
Active, not recruiting
- Stage III Cutaneous Melanoma AJCC v7
- +2 more
- Computed Tomography
- +3 more
-
Birmingham, Alabama
- +759 more
Aug 18, 2022
Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,
Active, not recruiting
- Metastatic Melanoma
- +2 more
- Ibrutinib
- +3 more
-
Los Angeles, California
- +12 more
Jul 27, 2022
BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,
Active, not recruiting
- BRAF V600E Mutation Present
- +9 more
- Dabrafenib
- +4 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,
Active, not recruiting
- Metastatic Malignant Neoplasm in the Brain
- +7 more
- Binimetinib
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Stage IIIC Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma Trial in United States
Active, not recruiting
- Stage IIIC Cutaneous Melanoma AJCC v7
- +2 more
- Bevacizumab
- Ipilimumab
-
Birmingham, Alabama
- +488 more
Mar 19, 2022
BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Melanoma Trial in Boston (drug, biological, other)
Terminated
- BRAF V600E Mutation Present
- +7 more
- Dabrafenib
- +4 more
-
Boston, Massachusetts
- +1 more
Mar 9, 2022
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly
Completed
- Cutaneous Melanoma
- +11 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +2 more
-
Chicago, Illinois
- +6 more
Nov 10, 2021
Cutaneous Melanoma, Mucosal Melanoma, Ocular Melanoma Trial in New York, Houston (biological, other, procedure)
Active, not recruiting
- Cutaneous Melanoma
- +10 more
- Ipilimumab
- +4 more
-
New York, New York
- +1 more
Aug 25, 2021
Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in Canada, United States
Active, not recruiting
- Melanoma of Unknown Primary
- +4 more
- Ipilimumab
- Alfa Interferon
-
Birmingham, Alabama
- +949 more
May 7, 2021
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Los Angeles, Salt Lake
Terminated
- Metastatic Melanoma
- +5 more
- Anti-SEMA4D Monoclonal Antibody VX15/2503
- +4 more
-
Los Angeles, California
- +1 more
Apr 1, 2021
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Recruiting
- Metastatic Melanoma
- +5 more
- Aldesleukin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 10, 2020
Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Mucosal Melanoma Trial in United States (Laboratory Biomarker
Completed
- Iris Melanoma
- +19 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +147 more
Jun 24, 2020
Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,
Completed
- Metastatic Melanoma
- +4 more
- Bevacizumab
- +4 more
-
San Francisco, California
- +12 more
Jan 7, 2020